151751-Najiba-Chargi

302 CHAPTER 16 Figure 1. Kaplan Meier curves and number at risk tables for overall survival (top) and disease-free sur - vival (bottom) in OPSCC patients with and without low SMM shows significant difference in OS (Log Rank χ 2= 4.30, p= 0.04) and a statistical trend towards decreased DFS (Log Rank χ 2= 3.35, p= 0.07) Figure 2. shows the Kaplan Meier survival curves and number at risk tables of overall and disease-free survival for OPSCC patients with and without sarcopenic obesity. Patients with sarcopenic obesity had a significant lower median OS (23.03; IQR 4.90-32.82) compared to patients without sarcopenic obesity (38.74; IQR 16.00-57.92) (Log rank χ 2= 4.60; p=0.03) with a 3-years OS rate of 39%versus 60%. Patients with sarcopenic obesity showed lower median DFS rate (23.66 months; IQR 5.48-33.35) compared to patients without sarcopenic obesity (32.35 months; IQR 10.60-57.08) (Log rank χ 2= 1.90, p= 0.17) with a 3-year DFS rate of 51% versus 70%.